Current antiviral therapy research is focused on developing dosage forms that enable highly
effective drug delivery, providing a selective effect in the organism, lower risk of adverse …

In spite of existing cases of severe viral infections with a high mortality rate, there are not
enough antiviral drugs and vaccines available for the prevention and treatment of such …

Type II (proteic) toxin–antitoxin (TA) operons are widely spread in bacteria and archaea.
They are organized as operons in which, usually, the antitoxin gene precedes the cognate …

In spite of existing cases of severe viral infections with a high mortality rate, there are not
enough antiviral drugs and vaccines available for the prevention and treatment of such …

Background: Viruses are the most devastating pathogens of almost all life forms including
humans and animals. Viruses can replicate very fast and may affect any metabolic and …

Viral infections represent a significant threat to global health due to their highly
communicable and potentially lethal nature. Conventional antiviral interventions encounter …

Chikungunya infection, although rarely fatal, is associated with significant morbidity which
necessitates its diagnosis in the initial stages. Currently for diagnosis, together with clinical …

Despite the advances in public health during the 18th and 19th centuries and the introduc‐-
tion of immunization and antibiotics in the 20th century, bacterial infection is among the most …

Peptidomimetic HIV protease inhibitors are an important class of drugs used in the treatment
of AIDS. The synthesis of a new type of diol‐based peptidomimetics is described. Our route …

Unfortunately, to date, there is no approved specific antiviral drug treatment against COVID-
19. Due to the costly and time-consuming nature of the de novo drug discovery and …